vs
Side-by-side financial comparison of Canaan Inc. (CAN) and Karyopharm Therapeutics Inc. (KPTI). Click either name above to swap in a different company.
Karyopharm Therapeutics Inc. is the larger business by last-quarter revenue ($34.1M vs $20.8M, roughly 1.6× Canaan Inc.). Canaan Inc. runs the higher net margin — -18.4% vs -299.9%, a 281.4% gap on every dollar of revenue.
Canaan Inc., doing business as Canaan Creative and known simply as Canaan, is a Singapore-based computer hardware manufacturer. Established in 2013 by N.G. Zhang, Canaan specializes in Blockchain servers and ASIC microprocessors for use in bitcoin mining.
CAN vs KPTI — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $20.8M | $34.1M |
| Net Profit | $-3.8M | $-102.2M |
| Gross Margin | 99.9% | — |
| Operating Margin | -15.9% | -52.4% |
| Net Margin | -18.4% | -299.9% |
| Revenue YoY | — | 11.6% |
| Net Profit YoY | — | -232.0% |
| EPS (diluted) | $-0.05 | $-7.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $20.8M | $34.1M | ||
| Q3 25 | $13.8M | $44.0M | ||
| Q2 25 | $11.4M | $37.9M | ||
| Q1 25 | — | $30.0M | ||
| Q4 24 | — | $30.5M | ||
| Q3 24 | $10.2M | $38.8M | ||
| Q2 24 | $4.8M | $42.8M | ||
| Q1 24 | — | $33.1M |
| Q4 25 | $-3.8M | $-102.2M | ||
| Q3 25 | $-1.5M | $-33.1M | ||
| Q2 25 | $-11.9M | $-37.3M | ||
| Q1 25 | — | $-23.5M | ||
| Q4 24 | — | $-30.8M | ||
| Q3 24 | $-10.4M | $-32.1M | ||
| Q2 24 | $-5.4M | $23.8M | ||
| Q1 24 | — | $-37.4M |
| Q4 25 | 99.9% | — | ||
| Q3 25 | 99.9% | — | ||
| Q2 25 | 99.9% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 99.9% | — | ||
| Q2 24 | 99.8% | — | ||
| Q1 24 | — | — |
| Q4 25 | -15.9% | -52.4% | ||
| Q3 25 | -27.0% | -34.6% | ||
| Q2 25 | -45.5% | -64.3% | ||
| Q1 25 | — | -110.8% | ||
| Q4 24 | — | -102.4% | ||
| Q3 24 | -77.2% | -67.8% | ||
| Q2 24 | -193.9% | -65.7% | ||
| Q1 24 | — | -101.9% |
| Q4 25 | -18.4% | -299.9% | ||
| Q3 25 | -11.0% | -75.2% | ||
| Q2 25 | -104.4% | -98.2% | ||
| Q1 25 | — | -78.2% | ||
| Q4 24 | — | -100.8% | ||
| Q3 24 | -102.7% | -82.7% | ||
| Q2 24 | -112.3% | 55.6% | ||
| Q1 24 | — | -112.8% |
| Q4 25 | $-0.05 | $-7.02 | ||
| Q3 25 | $-0.02 | $-3.82 | ||
| Q2 25 | $-0.25 | $-4.32 | ||
| Q1 25 | — | $-2.77 | ||
| Q4 24 | — | $-2.33 | ||
| Q3 24 | — | $-3.85 | ||
| Q2 24 | — | $-2.97 | ||
| Q1 24 | — | $-4.85 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $60.5M |
| Total DebtLower is stronger | $6.2M | — |
| Stockholders' EquityBook value | $52.4M | $-292.9M |
| Total Assets | $92.5M | $108.4M |
| Debt / EquityLower = less leverage | 0.12× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $60.5M | ||
| Q3 25 | — | $37.7M | ||
| Q2 25 | — | $38.7M | ||
| Q1 25 | — | $38.8M | ||
| Q4 24 | — | $62.5M | ||
| Q3 24 | — | $72.8M | ||
| Q2 24 | — | $84.8M | ||
| Q1 24 | — | $30.6M |
| Q4 25 | $6.2M | — | ||
| Q3 25 | $6.2M | — | ||
| Q2 25 | $6.2M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $52.4M | $-292.9M | ||
| Q3 25 | $44.7M | $-269.3M | ||
| Q2 25 | $33.8M | $-238.9M | ||
| Q1 25 | — | $-205.9M | ||
| Q4 24 | — | $-186.0M | ||
| Q3 24 | $43.6M | $-159.6M | ||
| Q2 24 | $56.8M | $-132.1M | ||
| Q1 24 | — | $-169.0M |
| Q4 25 | $92.5M | $108.4M | ||
| Q3 25 | $81.7M | $96.2M | ||
| Q2 25 | $78.0M | $104.9M | ||
| Q1 25 | — | $127.7M | ||
| Q4 24 | — | $164.4M | ||
| Q3 24 | $69.3M | $189.5M | ||
| Q2 24 | $73.7M | $214.0M | ||
| Q1 24 | — | $204.5M |
| Q4 25 | 0.12× | — | ||
| Q3 25 | 0.14× | — | ||
| Q2 25 | 0.18× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-11.8M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-11.8M | ||
| Q3 25 | — | $-5.9M | ||
| Q2 25 | — | $-18.7M | ||
| Q1 25 | — | $-39.0M | ||
| Q4 24 | — | $-25.8M | ||
| Q3 24 | — | $-19.5M | ||
| Q2 24 | — | $-38.5M | ||
| Q1 24 | — | $-43.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $-25.9M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $-43.9M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -84.7% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -132.6% |
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.0% | ||
| Q4 24 | — | 0.2% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.6% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -1.62× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CAN
Segment breakdown not available.
KPTI
| Products | $32.1M | 94% |
| License And Other | $2.0M | 6% |
